StockWatch
·

Strides Pharma Science Ltd Q3 FY25 Results

STARQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue1.2K4.0%
Total Income1.2K5.7%
Expenditure1.0K4.9%
PBT112.8911.6%
Net Profit90.043.9%
OPM0.58%3.36pp
NPM7.68%0.98pp
EPS9.565.7%
View full financials

Informational and educational content only. Not investment advice.